EBMT 2023 | EBMT session highlights: latest advances in cell therapy
Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, outlines the key topics that will be discussed at the symposium on the latest advances in cell therapy that is being held at this year’s EBMT congress. Prof. Chabannon explains that the symposium will focus on the feasibility of decentralized CAR-T manufacturing, developments in next-generation CAR-Ts, and how to increase the efficacy of allogeneic transplantation whilst reducing the risk of graft-versus-host disease (GvHD). This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
BELLICUM PHARMACEUTICALS: Membership on an entity’s Board of Directors or advisory committees
BMS/CELGENE: Speakers Bureau, Membership on an entity’s Board of Directors or advisory committees
EBMT: Membership on an entity’s Board of Directors or advisory committees
FRESENIUS KABI: Research Funding
KITE/GILEAD: Honoraria, Speakers Bureau, Membership on an entity’s Board of Directors or advisory committees
JANSSEN PHARMACEUTICALS: Membership on an entity’s Board of Directors or advisory committees
JAZZ: Honoraria
MILTENYI BIOTECH: Research Funding
NOVARTIS: Speakers Bureau
SANOFI SA: Speakers Bureau, Honoraria, Research Funding
TERUMO BCT: Speakers Bureau
